5AM VENTURES V, L.P. sold 10.2% of their position (125K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $866.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 6 sales
Filed: 7/1/2025ACC: 0001415889-25-018822
10% Owner
Since Oct 2021
-125K
Net shares
Net seller
$866.6K
Total sold
6
Open market trades
0B · 6S
6
Total transactions
125K disposed
Non-Derivative Transactions6
Common Stock
Direct
Shares
−55.73K
Price / share
$6.91
Trade value
$385.13K
% of position
1.7%
6/27/2025
3.28M→3.22M
Common Stock
Indirect
Shares
−19.27K
Price / share
$6.91
Trade value
$133.12K
% of position
1.7%
6/27/2025
1.13M→1.11M
Common Stock
Direct
Shares
−18.58K
Price / share
$6.81
Trade value
$126.57K
% of position
0.6%
6/30/2025
3.22M→3.20M
Common Stock
Indirect
Shares
−6.42K
Price / share
$6.81
Trade value
$43.75K
% of position
0.6%
6/30/2025
1.11M→1.11M
Common Stock
Direct
Shares
−18.58K
Price / share
$7.12
Trade value
$132.32K
% of position
0.6%
7/1/2025
3.20M→3.18M
Common Stock
Indirect
Shares
−6.42K
Price / share
$7.12
Trade value
$45.74K
% of position
0.6%
7/1/2025
1.11M→1.10M
Total
Net shares
−125K
Net value
-$866.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/27/2025 | S · Sale | −55.73K | $6.91 | $385.13K | 1.7% | 3.28M | 3.22M |
| Common Stock Indirect | 6/27/2025 | S · Sale | −19.27K | $6.91 | $133.12K | 1.7% | 1.13M | 1.11M |
| Common Stock Direct | 6/30/2025 | S · Sale | −18.58K | $6.81 | $126.57K | 0.6% | 3.22M | 3.20M |
| Common Stock Indirect | 6/30/2025 | S · Sale | −6.42K | $6.81 | $43.75K | 0.6% | 1.11M | 1.11M |
| Common Stock Direct | 7/1/2025 | S · Sale | −18.58K | $7.12 | $132.32K | 0.6% | 3.20M | 3.18M |
| Common Stock Indirect | 7/1/2025 | S · Sale | −6.42K | $7.12 | $45.74K | 0.6% | 1.11M | 1.10M |
| Total | −125K | -$866.63K | ||||||
Derivative Transactions0
No derivative transactions reported